To monitor AKT activation in a PTEN loss–driven prostate cancer model, the Akt-FRET biosensor mice were crossed with either the Pten−/+ model or the mutant PtenG129E/+ knock-in mouse line expressing a lipid phosphatase dead PTEN. The gene discussed is AKT1; the disease is prostate cancer.